ALINA HEDBERG: Open Payments
NPI 1326409517 · NOBLESVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 13 payments from 11 companies in 2025. Trend: 2023 $69 · 2024 $197 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $48 |
| ABBVIE INC. | 2 | $46 |
| SANOFI-AVENTIS U.S. LLC | 1 | $30 |
| Lilly USA, LLC | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Amgen Inc. | 1 | $19 |
| Dynavax Technologies Corporation | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: TZIELD, MOUNJARO, Wegovy, QULIPTA, Kerendia, Veozah, Auvelity, Ozempic.
Industry payments across IN — which companies pay providers there.
